T-Cell/Primary Cutaneous Lymphomas Panel - Disclosures
|
Panel Member
|
Weiyun Ai MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Stephen Ansell MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jeffrey Barnes MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Stefan Barta MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marian Birkeland PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jonathan Brammer MD |
|
Grant/Research Support
|
| Celgene Corporation | Incyte Corporation |
|
Date Completed
|
10/07/2024 |
|
Panel Member
|
Kenneth Carson MD, PhD |
|
Equity Interest/Stock Options
|
| Tempus Labs, Inc |
|
Grant/Research Support
|
| EMD Serono |
|
Date Completed
|
02/04/2025 |
|
Panel Member
|
Mark Clemens MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Utpal Davé MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ahmet Dogan MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Mary Dwyer MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Meghan Fay BSN, RN, OCN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Tanya Fischer MEd, MLIS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Francine Foss MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Zachary Frosch MD, MSHP |
|
Grant/Research Support
|
| AbbVie, Inc. | Acerta Pharma | Amgen Inc. | Antigenics Inc. | AstraZeneca Pharmaceuticals LP | Genmab | Merck & Co., Inc. | Roche Laboratories, Inc. | sanofi-aventis U.S. |
|
Date Completed
|
07/25/2024 |
|
Panel Member
|
Aaron Goodman MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ahmad Halwani MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Bradley Haverkos MD, MPH, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Megan Hollasch |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Richard Hoppe MD |
|
Equity Interest/Stock Options
|
| General Electric | Johnson & Johnson | Pfizer Inc. |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Steven Horwitz MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Eric Jacobsen MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Deepa Jagadeesh MD, MPH |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP | Atara biopharmaceuticals | Debiopharm | LOXO oncology | MEI pharma | Regeneron Pharmaceuticals, Inc. | Trillium pharmaceuticals |
|
Date Completed
|
03/24/2025 |
|
Panel Member
|
Allison Jones MD, FAAD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ann Karosas RPh, BCOP |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Youn Kim MD |
|
Grant/Research Support
|
| Corvus | CRISPR | Dren Bio | Innate | Kyowa Hakko Kirin Co., Ltd. | Pfizer Inc. | SeaGen |
|
Date Completed
|
06/08/2024 |
|
Panel Member
|
Kiran Kumar MD, MBA |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP |
|
Date Completed
|
07/22/2024 |
|
Panel Member
|
Neha Mehta-Shah MD, MSCI |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP | Bristol Myers Squibb | C4 Therapeutics | Celgene Corporation | Corvus | Daiichi- Sankyo Co. | Dizal Pharmaceuticals | Genentech, Inc. | Incyte Corporation | MorphoSys AG | Novartis Pharmaceuticals Corporation | SeaGen | Secura Bio | Yingli |
|
Date Completed
|
03/24/2025 |
|
Panel Member
|
John Murphy |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Elise Olsen MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Dorothy Pan MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Saurabh Rajguru MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Peter Riedell MD |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP | Bristol Myers Squibb | Calibr | CARGO Therapeutics | Cellectis | CRISPR Therapeutics | Fate Therapeutics | Genentech, Inc. | Kite Pharma | Tessa Therapeutics | Xencor |
|
Date Completed
|
01/20/2025 |
|
Panel Member
|
Sima Rozati MD, PhD |
|
Grant/Research Support
|
| Kyowa Hakko Kirin Co., Ltd. |
|
Date Completed
|
05/06/2024 |
|
Panel Member
|
Jonathan Said MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicholas Sansone MA |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Aaron Shaver MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Lauren Shea MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Michi Shinohara MD |
|
Grant/Research Support
|
| Kyowa Hakko Kirin Co., Ltd. |
|
Date Completed
|
06/19/2024 |
|
Panel Member
|
Matthew Stephany MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Hema Sundar PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Susan Thornton |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Carlos Torres-Cabala MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ryan Wilcox MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Peggy Wu MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Yumeng Zhang MD |
|
Product/Speakers Bureau
|
| Acrotech Biopharma |
|
Date Completed
|
05/01/2025 |
